DOX Quote, Financials, Valuation and Earnings

RingCentral has a net margin of 6.84% compared to Amdocs's net margin of -1.29%. Amdocs's return on equity of 13.85% beat RingCentral's return on equity of --.

Amdocs has a consensus price target of --, signalling upside risk potential of 17.39%. On the other hand RingCentral has an analysts' consensus of $43.37 which suggests that it could grow by 15.8%. Given that Amdocs has higher upside potential than RingCentral, analysts believe Amdocs is more attractive than RingCentral.

Amdocs has a beta of 0.717, which suggesting that the stock is 28.33% less volatile than S&P 500. In comparison RingCentral has a beta of 0.987, suggesting its less volatile than the S&P 500 by 1.329%.

Amdocs has a quarterly dividend of $0.48 per share corresponding to a yield of 2.15%. RingCentral offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Amdocs pays 42.98% of its earnings as a dividend. RingCentral pays out -- of its earnings as a dividend. Amdocs's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Amdocs quarterly revenues are $1.3B, which are larger than RingCentral quarterly revenues of $608.8M. Amdocs's net income of $86.4M is higher than RingCentral's net income of -$7.9M. Notably, Amdocs's price-to-earnings ratio is 20.52x while RingCentral's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Amdocs is 1.98x versus 1.48x for RingCentral. Usually stocks with elevated PS ratios are considered overvalued.

Signing Day Sports has a net margin of 6.84% compared to Amdocs's net margin of -2893.73%. Amdocs's return on equity of 13.85% beat Signing Day Sports's return on equity of --.

Amdocs has a consensus price target of --, signalling upside risk potential of 17.39%. On the other hand Signing Day Sports has an analysts' consensus of -- which suggests that it could fall by --. Given that Amdocs has higher upside potential than Signing Day Sports, analysts believe Amdocs is more attractive than Signing Day Sports.

Amdocs has a beta of 0.717, which suggesting that the stock is 28.33% less volatile than S&P 500. In comparison Signing Day Sports has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Amdocs has a quarterly dividend of $0.48 per share corresponding to a yield of 2.15%. Signing Day Sports offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Amdocs pays 42.98% of its earnings as a dividend. Signing Day Sports pays out -14.6% of its earnings as a dividend. Amdocs's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Amdocs quarterly revenues are $1.3B, which are larger than Signing Day Sports quarterly revenues of $55.4K. Amdocs's net income of $86.4M is higher than Signing Day Sports's net income of -$1.6M. Notably, Amdocs's price-to-earnings ratio is 20.52x while Signing Day Sports's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Amdocs is 1.98x versus 1.65x for Signing Day Sports. Usually stocks with elevated PS ratios are considered overvalued.

Twilio has a net margin of 6.84% compared to Amdocs's net margin of -0.86%. Amdocs's return on equity of 13.85% beat Twilio's return on equity of -5.02%.

Amdocs has a consensus price target of --, signalling upside risk potential of 17.39%. On the other hand Twilio has an analysts' consensus of $94.06 which suggests that it could fall by -12.85%. Given that Amdocs has higher upside potential than Twilio, analysts believe Amdocs is more attractive than Twilio.

Amdocs has a beta of 0.717, which suggesting that the stock is 28.33% less volatile than S&P 500. In comparison Twilio has a beta of 1.382, suggesting its more volatile than the S&P 500 by 38.246%.

Amdocs has a quarterly dividend of $0.48 per share corresponding to a yield of 2.15%. Twilio offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Amdocs pays 42.98% of its earnings as a dividend. Twilio pays out -- of its earnings as a dividend. Amdocs's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Amdocs quarterly revenues are $1.3B, which are larger than Twilio quarterly revenues of $1.1B. Amdocs's net income of $86.4M is higher than Twilio's net income of -$9.7M. Notably, Amdocs's price-to-earnings ratio is 20.52x while Twilio's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Amdocs is 1.98x versus 4.30x for Twilio. Usually stocks with elevated PS ratios are considered overvalued.

WidePoint has a net margin of 6.84% compared to Amdocs's net margin of -1.23%. Amdocs's return on equity of 13.85% beat WidePoint's return on equity of -20.12%.

Amdocs has a consensus price target of --, signalling upside risk potential of 17.39%. On the other hand WidePoint has an analysts' consensus of -- which suggests that it could grow by 40.39%. Given that WidePoint has higher upside potential than Amdocs, analysts believe WidePoint is more attractive than Amdocs.

Amdocs has a beta of 0.717, which suggesting that the stock is 28.33% less volatile than S&P 500. In comparison WidePoint has a beta of 1.716, suggesting its more volatile than the S&P 500 by 71.645%.

Amdocs has a quarterly dividend of $0.48 per share corresponding to a yield of 2.15%. WidePoint offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Amdocs pays 42.98% of its earnings as a dividend. WidePoint pays out -- of its earnings as a dividend. Amdocs's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Amdocs quarterly revenues are $1.3B, which are larger than WidePoint quarterly revenues of $34.6M. Amdocs's net income of $86.4M is higher than WidePoint's net income of -$425.2K. Notably, Amdocs's price-to-earnings ratio is 20.52x while WidePoint's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Amdocs is 1.98x versus 0.32x for WidePoint. Usually stocks with elevated PS ratios are considered overvalued.